Modification of the risk of post-traumatic stress disorder (PTSD) by the 5-HTTLPR polymorphisms after Lorca's earthquakes (Murcia, Spain).


Journal

Psychiatry research
ISSN: 1872-7123
Titre abrégé: Psychiatry Res
Pays: Ireland
ID NLM: 7911385

Informations de publication

Date de publication:
12 2019
Historique:
received: 09 07 2019
revised: 13 10 2019
accepted: 24 10 2019
pubmed: 16 11 2019
medline: 29 4 2020
entrez: 16 11 2019
Statut: ppublish

Résumé

Information of the modulation effect of the serotonin transporter gene-linked polymorphic region (5-HTTLPR) on post-traumatic stress disorder (PTSD) after earthquakes is scarce and contradictory. A cross-sectional face-to-face interview survey of a representative sample of the adults was carried out after the Lorca (Spain) earthquakes (May 11, 2011). Socio-demographic variables, DSM-IV diagnostic assessment and earthquake-related stressors were obtained from the Composite International Diagnostic Interview (CIDI). The triallelic and biallelic classification of the 5-HTTLPR polymorphism were genotyped from buccal swabs. Multivariate logistic regression models were used to predict PTSD, including interaction terms to explore gene-environment (G x E) interactions. The vast majority (83%, n = 341) of the Lorca survey respondents (n = 412, 71% response rate) were genotyped. Both classifications of the 5-HTTLPR genotype were in Hardy-Weinberg equilibrium. Prior lifetime PTSD was the only variable that remained a significant predictor after adjustments. There were no significant main effects of earthquake related stressors or 5-HTTLPR. However, G x E interactions of 5-HTTLPR with high emotional impact and prior lifetime anxiety disorders were statistically significant. These results provide new evidence of the modulation effect of the 5-HTTLPR polymorphisms on PTSD risk. This information might characterize people at higher risk of developing PTSD after an earthquake exposure.

Identifiants

pubmed: 31727442
pii: S0165-1781(19)31466-0
doi: 10.1016/j.psychres.2019.112640
pmc: PMC7436333
mid: NIHMS1617625
pii:
doi:

Substances chimiques

SLC6A4 protein, human 0
Serotonin Plasma Membrane Transport Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

112640

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA016558
Pays : United States
Organisme : FIC NIH HHS
ID : R03 TW006481
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH069864
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH070884
Pays : United States
Organisme : NIMH NIH HHS
ID : R13 MH066849
Pays : United States

Informations de copyright

Copyright © 2019. Published by Elsevier B.V.

Références

Mol Psychiatry. 2000 Jan;5(1):32-8
pubmed: 10673766
BMC Psychiatry. 2016 Jun 07;16:188
pubmed: 27267874
Int J Methods Psychiatr Res. 2008 Dec;17 Suppl 2:S6-S20
pubmed: 19035440
Mol Psychiatry. 2018 Sep;23(9):1892-1899
pubmed: 28924183
Neuropharmacology. 2012 Feb;62(2):654-62
pubmed: 21439305
Arch Gen Psychiatry. 2005 Jun;62(6):593-602
pubmed: 15939837
Ann Intern Med. 2009 Feb 3;150(3):206-15
pubmed: 19189911
Epidemiol Rev. 2005;27:78-91
pubmed: 15958429
Clin Psychol Rev. 2017 Jun;54:81-95
pubmed: 28445840
J Nerv Ment Dis. 2002 Apr;190(4):209-18
pubmed: 11960081
Biol Psychiatry. 2007 Sep 15;62(6):588-92
pubmed: 17336939
Am J Epidemiol. 2009 Mar 15;169(6):704-11
pubmed: 19228812
Science. 1996 Nov 29;274(5292):1527-31
pubmed: 8929413
Am J Psychiatry. 2009 Aug;166(8):926-33
pubmed: 19487392
J Trauma Stress. 2009 Jun;22(3):240-3
pubmed: 19444877
PLoS One. 2013 Jun 25;8(6):e66227
pubmed: 23825531
Int J Methods Psychiatr Res. 2006;15(4):167-80
pubmed: 17266013
J Postgrad Med. 2006 Apr-Jun;52(2):121-5
pubmed: 16679676
Am J Psychiatry. 2010 May;167(5):509-27
pubmed: 20231323
Psychiatr Genet. 2004 Sep;14(3):121-9
pubmed: 15318024
Alcohol Clin Exp Res. 2005 Jan;29(1):8-16
pubmed: 15654286
Psychol Med. 2017 Oct;47(13):2260-2274
pubmed: 28385165
Depress Anxiety. 2011 Aug;28(8):639-47
pubmed: 21608084
Br J Psychiatry. 2010 Nov;197(5):378-85
pubmed: 21037215
Depress Anxiety. 2009;26(11):993-7
pubmed: 19842167
JAMA. 2012 May 2;307(17):1805-6
pubmed: 22550194
Biol Res Nurs. 2015 Jul;17(4):364-72
pubmed: 26002549
Psychol Med. 2016 Jan;46(2):327-43
pubmed: 26511595
Am J Psychiatry. 2006 Jan;163(1):48-51
pubmed: 16390888
Int J Methods Psychiatr Res. 2004;13(2):93-121
pubmed: 15297906
Mol Psychiatry. 2007 Jan;12(1):47-54
pubmed: 16969368
Am J Psychiatry. 2007 Nov;164(11):1693-9
pubmed: 17974934
Psychiatry. 2002 Fall;65(3):240-60
pubmed: 12405080
Eur J Psychotraumatol. 2017 Oct 27;8(sup5):1353383
pubmed: 29075426
World Psychiatry. 2014 Oct;13(3):265-74
pubmed: 25273300
J Adv Nurs. 2016 May;72(5):980-1000
pubmed: 26748456
Epidemiol Rev. 1995;17(1):113-9
pubmed: 8521929
J Trauma Stress. 2009 Oct;22(5):416-26
pubmed: 19743189
J Consult Clin Psychol. 2000 Oct;68(5):748-66
pubmed: 11068961
PLoS One. 2015 Sep 22;10(9):e0137293
pubmed: 26394150
Neuropsychopharmacology. 2015 Sep;40(10):2287-97
pubmed: 25904361
J Affect Disord. 2014 Jun;161:91-6
pubmed: 24751314
Neuropsychobiology. 2006;53(1):1-8
pubmed: 16319503
J Trauma Stress. 2007 Oct;20(5):737-50
pubmed: 17955543
BMJ Open. 2013 Dec 03;3(12):e004035
pubmed: 24302509
Am J Psychiatry. 2006 Sep;163(9):1588-93
pubmed: 16946185
Psychol Med. 2017 Jan;47(2):227-241
pubmed: 27573281
J Clin Psychiatry. 2010 May;71(5):543-7
pubmed: 20441718
PLoS One. 2017 Jul 19;12(7):e0179690
pubmed: 28723949
Gac Sanit. 2013 Jul-Aug;27(4):325-31
pubmed: 22842058
Sci Rep. 2017 Nov 28;7(1):16532
pubmed: 29184054
PLoS One. 2014 May 06;9(5):e96644
pubmed: 24800944
J Clin Epidemiol. 2001 Apr;54(4):343-9
pubmed: 11297884
Int J Methods Psychiatr Res. 2004;13(2):122-39
pubmed: 15297907
J Trauma Stress. 2013 Dec;26(6):645-53
pubmed: 24222274
Eur Arch Psychiatry Clin Neurosci. 2008 Mar;258(2):82-96
pubmed: 18297420
Epidemiology. 1990 Jan;1(1):43-6
pubmed: 2081237
Psychol Med. 2008 Apr;38(4):467-80
pubmed: 17803838
Psychiatry. 2002 Fall;65(3):207-39
pubmed: 12405079
Curr Trauma Rep. 2018;4(2):103-108
pubmed: 29888166
Mol Psychiatry. 2018 Mar;23(3):666-673
pubmed: 28439101
Int J Psychol. 2019 Aug 23;:
pubmed: 31441508
Anxiety Stress Coping. 2018 May;31(3):318-327
pubmed: 29280387
Neuropsychopharmacology. 2016 Jan;41(1):297-319
pubmed: 26321314
Nat Rev Dis Primers. 2015 Oct 08;1:15057
pubmed: 27189040
J Nerv Ment Dis. 2013 Dec;201(12):1045-52
pubmed: 24284639
Int J Methods Psychiatr Res. 2008 Dec;17 Suppl 2:S21-8
pubmed: 19035439

Auteurs

Fernando Navarro-Mateu (F)

Unidad de Docencia, Investigación y Formación en Salud Mental (UDIF-SM). Servicio Murciano de Salud. Murcia, Spain; Departamento de Psicología Básica y Metodología, Universidad de Murcia. Murcia, Spain; CIBER in Epidemiology & Public Health (CIBERESP). Madrid, Spain; IMIB-Arrixaca. Murcia, Spain. Electronic address: fernando.navarro@carm.es.

Teresa Escámez (T)

IMIB-Arrixaca. Murcia, Spain; BIOBANC-MUR. IMIB Arrixaca. Murcia, Spain; Spanish Biobaks Platform, ISCIII. Madrid, Spain.

M Paz Quesada (MP)

IMIB-Arrixaca. Murcia, Spain.

M José Alcaráz (MJ)

Fundación para la Formación e Investigación Sanitarias (FFIS) de la Región de Murcia. Murcia, Spain.

Gemma Vilagut (G)

CIBER in Epidemiology & Public Health (CIBERESP). Madrid, Spain; IM-Institut Hospital del Mar d´Investigacions Médiques. Barcelona, Spain.

Diego Salmerón (D)

CIBER in Epidemiology & Public Health (CIBERESP). Madrid, Spain; IMIB-Arrixaca. Murcia, Spain; Departamento de Ciencias Sociosanitarias, Universidad de Murcia. Murcia, Spain.

José M Huerta (JM)

CIBER in Epidemiology & Public Health (CIBERESP). Madrid, Spain; IMIB-Arrixaca. Murcia, Spain; Department of Epidemiology, Murcia Health Council, Murcia, Spain.

M Dolores Chirlaque (MD)

CIBER in Epidemiology & Public Health (CIBERESP). Madrid, Spain; IMIB-Arrixaca. Murcia, Spain; Departamento de Ciencias Sociosanitarias, Universidad de Murcia. Murcia, Spain; Department of Epidemiology, Murcia Health Council, Murcia, Spain.

Carmen Navarro (C)

CIBER in Epidemiology & Public Health (CIBERESP). Madrid, Spain; IMIB-Arrixaca. Murcia, Spain; Departamento de Ciencias Sociosanitarias, Universidad de Murcia. Murcia, Spain; Department of Epidemiology, Murcia Health Council, Murcia, Spain.

Ronald C Kessler (RC)

Department of Health Care Policy, Harvard Medical School. Boston, USA.

Jordi Alonso (J)

CIBER in Epidemiology & Public Health (CIBERESP). Madrid, Spain; IM-Institut Hospital del Mar d´Investigacions Médiques. Barcelona, Spain; Departamento de Salud y Ciencias Experimentales, Universidad Pompeu Fabra, Barcelona, Spain.

Salvador Martínez (S)

Instituto de Neurociencias UMH-CSIC. Alicante, Spain; CIBER in Mental Health (CIBERSAM). Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH